How Michael Friedrich Raised Over 50M For a Medical Device Startup
Michael Friedrich turned a near-failure into a
2.5M exit, then invested it all to build a surgical robotics company that raised over
50M. We break down his playbook.
TL;DR: After forcing an acquisition of his first med-tech startup, Aïmago, for
2.5M, Michael Friedrich invested his entire exit into Distalmotion. He scaled the surgical robotics company by targeting the 99% of hospitals ignored by incumbents, raising over
50M by leveraging a powerful second-time founder narrative and deep market insight.
Key takeaways
- To force an acquisition, create pressure on a public competitor’s stock price by targeting their investors and analysts.
- When choosing your next venture, look for a massive, underserved market segment that incumbents are too slow or expensive to capture.
- Leverage your track record: bring previous investors into your new venture by showing them you can navigate adversity.
- In capital-intensive fields like med-tech, map out your entire funding roadmap to commercialization and be transparent with investors.
- Don't just build a better product; build a better business model. Distalmotion won by making robotics accessible to more hospitals.
- Full conviction matters. Investing your own exit proceeds sends a powerful signal to new investors.
Your First Exit Isn’t the End. It’s Seed Money for Your Real Ambition.
Michael Friedrich raised over 50 million for his surgical robotics company, Distalmotion. But the story starts with his first company, Aïmago SA, a medical device startup that was on the verge of failure.
Instead of letting it die, he engineered a
2.5 million exit by forcing a public competitor to acquire him. Then, he invested every dollar of his earnings into his next venture. This is the playbook for leveraging a small win into a massive one.
The "Forced Acquisition": A Masterclass in M&A Strategy
Aïmago SA had a classic startup problem: a brilliant piece of engineering that nobody wanted to buy. Their blood flow imaging camera was technically superior but failing to gain commercial traction. The company was running out of road.
The conventional move is to package the company up and shop it to the corporate development departments of large incumbents, hoping for a sympathetic ear. This rarely works. A better approach is to make ignoring you more painful than acquiring you.
Friedrich’s team targeted a publicly-traded competitor whose entire market capitalization was built on an older, inferior technology. The strategy was audacious: wage a silent campaign against their stock price.
How to Engineer a "Forced" Acquisition
This is a high-risk, high-reward strategy, but it provides a clear lesson in leverage. You don't need permission from a competitor to make their life difficult.
Continue reading the full guide
Related guides
